Cargando…
Xenogeneic Transplantation of Human Placenta-Derived Mesenchymal Stem Cells Alleviates Renal Injury and Reduces Inflammation in a Mouse Model of Lupus Nephritis
Human placenta-derived mesenchymal stem cells (pMSCs) are considered a good source for cell therapy. The purpose of this study was to observe whether the transplantation of human pMSCs would affect the treatment of lupus nephritis (LN)-prone MRL/lpr mice. Multiple injections (at the 16th, 18th, and...
Autores principales: | Liu, Juan, Lu, Xuehong, Lou, Yan, Cai, Yong, Cui, Wenpeng, Wang, Jing, Nie, Ping, Chen, Liangmei, Li, Bing, Luo, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421051/ https://www.ncbi.nlm.nih.gov/pubmed/30941373 http://dx.doi.org/10.1155/2019/9370919 |
Ejemplares similares
-
Immunomodulatory Activity of Mesenchymal Stem Cells in Lupus Nephritis: Advances and Applications
por: Li, Jicui, et al.
Publicado: (2022) -
Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis
por: Yung, Susan, et al.
Publicado: (2017) -
Outcome and Prognosis of Patients With Lupus Nephritis Submitted to Renal Transplantation
por: Albuquerque, Bruna Coelho, et al.
Publicado: (2019) -
Renal Fibrosis in Lupus Nephritis
por: Sciascia, Savino, et al.
Publicado: (2022) -
Mediators of Inflammation and Their Effect on Resident Renal Cells: Implications in Lupus Nephritis
por: Yung, Susan, et al.
Publicado: (2013)